A collaborative approach is critical to all the work of the Industry Genomics Network Alliance (InGeNA). InGeNA works on the principle that to make progress efficiently, there is a need to reduce duplication of effort and make a meaningful contribution. Above all, they want to be inclusive in everything they do.
InGeNA was formed in late 2020 to strengthen industry collaboration, coordinate on key issues and realise opportunities for all Australians to benefit from precision healthcare.
The companies who founded InGeNA under the auspices of the Australasian Institute of Digital Health (AIDH) are progressing programs to embed genomics across Australian healthcare.
Companies representing pathology, technology and biopharma sectors, contributed funding to start InGeNA matched by MTPConnect’s Industry Growth Centre Project Fund Program.
We are looking forward to collaborating with InGeNA on upcoming projects.
